scholarly article | Q13442814 |
P356 | DOI | 10.1080/00498250600598486 |
P698 | PubMed publication ID | 16854777 |
P2093 | author name string | P A Philip | |
H Lu | |||
J J Wang | |||
K K Chan | |||
P2860 | cites work | Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine | Q34448258 |
Cytochromes P-450 in rats: structures, functions, properties and relevant human forms | Q36255451 | ||
Ifosfamide--pharmacology, safety and therapeutic potential | Q39827086 | ||
Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450. | Q40416532 | ||
V79 Chinese hamster cells genetically engineered for cytochrome P450 and their use in mutagenicity and metabolism studies | Q40778289 | ||
Use of V79 cells with stably transfected cytochrome P450 cDNAs in studying the metabolism and effects of cytotoxic drugs | Q40977217 | ||
Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide | Q42285396 | ||
Activation of the anticancer prodrugs cyclophosphamide and ifosfamide: identification of cytochrome P450 2B enzymes and site-specific mutants with improved enzyme kinetics | Q44854955 | ||
Analysis of ifosfamide, 4-hydroxyifosfamide, N2-dechloroethylifosfamide, N3-dechloroethylifosfamide and iphosphoramide mustard in plasma by gas chromatography-mass spectrometry | Q46281480 | ||
Directed evolution of mammalian cytochrome P450 2B1: mutations outside of the active site enhance the metabolism of several substrates, including the anticancer prodrugs cyclophosphamide and ifosfamide | Q46387102 | ||
Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation | Q46430447 | ||
Activation of the anti-cancer drug ifosphamide by rat liver microsomal P450 enzymes | Q58483760 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ifosfamide | Q418560 |
stereoselectivity | Q903429 | ||
P304 | page(s) | 367-385 | |
P577 | publication date | 2006-05-01 | |
P1433 | published in | Xenobiotica | Q1360678 |
P1476 | title | Stereoselectivity in metabolism of ifosfamide by CYP3A4 and CYP2B6. | |
P478 | volume | 36 |
Q88658051 | Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition |
Q30520640 | Contributions of human enzymes in carcinogen metabolism |
Q47594127 | Stereochemical considerations in pharmacokinetic processes of representative antineoplastic agents |
Q36788391 | Stereoselectivity in drug metabolism |
Q47951404 | Therapeutic options for patients with lymphoma and liver dysfunction or failure during mechlorethamine shortage |
Search more.